← All trials
NCT04044001
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2019
- Primary completion
- Oct 31, 2020
- Completion date
- Nov 30, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 77
- Arms / groups
- 12 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Ludwig Maximilians UniversityLead sponsor
- Radboud UniversityCollaborator
- Ludwig Maximilians UniversitySponsor investigator
- German Federal Ministry of Education and ResearchCollaborator
- European and Developing Countries Clinical Trials Partnership (EDCTP)Collaborator
- Ludwig Maximilians UniversityStudy director
- TASK Applied ScienceOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.